N. Bhudia

Molecular Detection of Minimal Residual Disease Provides the Most Powerful Independent Prognostic Factor Irrespective of Clonal Architecture in Nucleophosmin (NPM1) Mutant Acute Myeloid Leukemia

P. Vyas, M. Simpson, R. Hills, 2014 .

Assessment of Minimal Residual Disease in Standard-Risk AML.

Yashma Patel, Robert K Hills, Hassan Farah, 2016, The New England journal of medicine.

Impact of collection and storage of lung tumor tissue on whole genome expression profiling.

A. Nicholson, M. Moffatt, M. Freidin, 2012, The Journal of molecular diagnostics : JMD.